CBT

Cabot Corp. 10-Q Summary: Quarter Ended June 30, 2002

Business Context and Reporting Period

This is an unaudited quarterly report (Form 10-Q) for Cabot Corporation for the three and nine months ended June 30, 2002. Cabot operates in three primary segments: Chemical Businesses (carbon black, fumed metal oxides, inkjet colorants), Performance Materials (tantalum powders), and Specialty Fluids (cesium formate). The period includes the full consolidation of Cabot Supermetals (CSM) following the acquisition of the remaining 50% interest in February 2002.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 11% in Q3 and 13% for the nine-month period. The Chemical Businesses saw a 3% Q3 decline due to pricing adjustments in carbon black, while Performance Materials sales dropped 34% in Q3 due to customer contract disputes and slower market conditions.
• Profitability Compression: Net income fell 50% in Q3 and 13% for the nine months. Profit before taxes and special items from continuing operations dropped 40% in Q3.
• Special Items: Q3 2002 included $7 million in special charges: a $5 million reserve increase for respirator claims from a divested business, a $3 million asset impairment for cancelled expansion projects at the Boyertown plant, and a $1 million insurance recovery benefit. Q3 2001 included $4 million in charges related to executive departures.
• Acquisition Impact: The acquisition of CSM added $70 million in goodwill and increased debt levels, though it expanded capacity in the tantalum business.

Outlook, Risks, and Management Commentary

• Segment Outlook: Management is cautiously optimistic about the carbon black business recovering from the bottom of the cycle, noting volume increases globally. However, the fourth quarter is traditionally weak due to seasonal factors. The Performance Materials segment remains cautious due to ongoing litigation with customer AVX and previous disputes with Kemet and Vishay.
• Liquidity: Cash provided by operating activities improved significantly to $107 million for the nine months, compared to a use of $44 million in the prior year, largely due to a large tax payment in the prior year related to the LNG business sale. Capital spending is expected to be approximately $280 million for fiscal 2002.
• Legal Contingencies:
  • Respirator Claims: Approximately 38,000 claims are pending. Cabot has reserved $6 million total but states it cannot estimate future liability ranges due to unpredictability.
  • AVX Litigation: A complaint filed July 29, 2002, alleges unfair trade practices. Cabot intends to defend vigorously.
  • Environmental: $27 million is reserved for environmental matters, primarily related to divested businesses.
• Market Risks: Significant exposure to foreign currency fluctuations, particularly the Japanese Yen (CSM debt) and currencies in Argentina and Brazil. Interest rate risk is managed via swaps.

Investor Verification Checklist

• Respirator Liability: Verify the assumptions behind the $6 million reserve and the potential for future claims to exceed current estimates, given the "unpredictable" nature of the litigation.
• Performance Materials Contracts: Monitor the resolution of the AVX lawsuit and the status of the Vishay contract extension to assess revenue stability in the tantalum segment.
• Carbon Black Margins: Confirm if pricing adjustments in the carbon black business have stabilized, as this was a primary driver of the profit decline in the Chemical segment.
• Debt Servicing: Review the impact of the increased debt-to-capital ratio (27%) and the specific terms of the Japanese Yen-denominated debt assumed in the CSM acquisition.
• Capital Allocation: Assess the return on the $89 million net cash outflow for the CSM acquisition and the $52 million spent on share repurchases.